Predictors of Survival for Patients with Non-small Cell Lung Cancer and Synchronous Brain Metastases with FDG-PET/CT Staging

Authors

N. Ohri, Thomas Jefferson University and HospitalsFollow
Y. Xiao, Thomas Jefferson University and HospitalsFollow
M. Werner-Wasik, Thomas Jefferson University and HospitalsFollow

Abstract

Purpose: The clinical course of patients diagnosed with non-small cell lung cancer (NSCLC) with brain metastases (BM) at presentation is variable. Here we seek to identify predictors of survival in patients staged with FDG-PET/CT.

American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting July 18-22, Philadelphia, PA

Recommended Citation

Ohri, N.; Xiao, Y.; and Werner-Wasik, M. (2010) "Predictors of Survival for Patients with Non-small Cell Lung Cancer and Synchronous Brain Metastases with FDG-PET/CT Staging," Bodine Journal: Vol. 3: Iss. 1, Article 15.
DOI: https://doi.org/10.29046/TBJ.003.1.014
Available at: https://jdc.jefferson.edu/bodinejournal/vol3/iss1/15